Validation of α-synuclein Modifications in Parkinson's dIsoRder Evolution
Conditions
Parkinson Disease (PD)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Aristotle University of Thessaloniki, Thessaloniki, Greece
Casa di Cura Igea, Milan, Mi, Italy
Instytut Psychiatrii I Neurologii, Warsaw, Poland
Asociacion Parkinson Madrid, Madrid, Spain
Contact: Study coordinator (Mayca Marin Valero) · investigacion@parkinsonmadrid.org · 0034 914 340406
Study leads
Marco Feligioni, PHD
Study Chair
EBRI-European Brain Research Insitute
Elda Judica, MD
Principal Investigator
Casa di Cura IGEA